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ABSTRACTSwas also a prognostic indicator for the OS (HR¼2.48, p¼0.035) in HCC
after resection.
Conclusions: Liver function prior to surgery and poor tumour differenti-
ation are prognostic factors for OS and PFS after resection.
0871: LAPAROSCOPIC SUBTOTAL CHOLECYSTECTOMY WITHOUT CYSTIC
DUCT LIGATION e AN ALTERNATIVE TO OPEN CONVERSION. A PRO-
SPECTIVE STUDY
Pavan Padaki 1, Himanshu Wadhawan 1, Sanjay Pandanaboyana 2,
Afshin Alijani 1. 1NHS Tayside, Dundee, UK; 2Royal Inﬁrmary of Edinburgh,
Edinburgh, UK.
Introduction: Laparoscopic cholecystectomy is the gold standard in the
treatment of symptomatic gallstones. The dissection of the calot's triangle
can be complicated by acute or chronic inﬂammation. Laparoscopic sub-
total cholecystectomy can be an alternative to open conversion for these
difﬁcult cases.
Methods: Prospective study of laparoscopic subtotal cholecystectomies
performed by a single surgeon in a teaching hospital from 2007 - 2011.
Total 179 cholecystectomies were performed, 162 were laparoscopic, 6
were open conversions, 1 open and 10 laparoscopic subtotal. 104 were
elective and 58 were emergency.
Results: Ten laparoscopic subtotal cholecystectomies without cystic duct
ligation were performed. Median age was 65 years (range 52-84 years).
Median duration of hospital stay was 7 days (range 7-40 days). 7 were
emergency and 3were elective. Operative ﬁndings included empyema in 4,
chronic cholecystitis in 2, acute in 3 and perforated gall bladder in 1. All
patients had an intra-abdominal drain placement. Bile leak occurred in
two patients, one settled spontaneously in 8 days and the other was
managed with an endoscopic retrograde cholangiopancreatography and
stent. No other complications were reported.
Conclusion: Laparoscopic subtotal cholecystectomy is an alternative to
open conversion in difﬁcult cases. Bile leak can occur but can be easily
managed.
0983: ROUTINE COAGULATION SCREENING IS AN UNNECESSARY STEP IN
PATIENTS WITHOUT EVIDENCE OF BIOCHEMICAL JAUNDICE PRIOR TO
ERCP
Jonathan Nicholls, Richard Egan, Michael Stechman. University Hospital of
Wales, Cardiff, UK.
Aims: UK guidelines recommend that patients undergoing endoscopic
retrograde cholangio-pancreatography (ERCP) should undergo coagulation
screening within 72 hours of the procedure. We hypothesised that coag-
ulation is rarely deranged without biochemical jaundice, making coagu-
lation screening unnecessary.
Methods: All ERCP procedures performed at our tertiary referral centre
between June 2011 and September 2012 were analysed. Demographics, pre-
procedure prothrombin time (PT), bilirubin levels, indications and pro-
cedures performed were recorded. 519 procedures were included, with 55
patients excluded due to incomplete records or anti-coagulation therapy.
Results: The cohort was divided into two groups: jaundiced (n¼266)
(elevated pre-procedure bilirubin) and non-jaundiced (n¼253) (normal
pre-procedure bilirubin). In the jaundiced group 6% had a signiﬁcantly
prolonged PT (international normalised ratio (INR) of1.5). In the non-
jaundiced group none had an INR1.5, 6% had a mildly raised PT
(INR¼1<x<1.5), with no bleeding complications. The PT between the
jaundiced and non-jaundiced groups was signiﬁcantly different (mean
conﬁdence interval; 12.90.65 vs. 11.10.14; p<0.001).
Conclusions: Our data suggests that patients with normal bilirubin levels
pre-ERCP rarely have deranged coagulation. In patients with a negative
bleeding history and normal liver function tests undergoing ERCP, we
suggest that coagulation screening is unnecessary. Focused coagulation
testing could represent an annual saving of over £370,000 nationally.
1034: COMMON BILE DUCT e DOES SIZE MATTER?
Anna Kamocka 1, Lisa Bradley 2, Nigel D'Souza 1, Andrew Gordon 1.
1Heatherwood and Wexham Park Hospitals NHS Foundation Trust, Slough,
Berkshire, UK; 2Ashford and St Peter's Hospitals NHS Trust, Chertsey, Surrey, UK.
Aims: To evaluate correlation between pre- and intraoperative common
bile duct (CBD) measurements and incidence of CBD stones at the routine
intraoperative cholangiogram(IOC).Methods: Retrospective review of patients undergoing laparoscopic cho-
lecystectomy with routine IOC at Wexham Park Hospital between Jan
2007-Jan 2010. CBD size at pre-operative imaging (USS, CT and/or MRCP)
and IOC were analysed alongside with incidence of CBD calculi.
Results: 78 patients underwent IOC. In 21(Group 1), CBD size was measured
preoperatively at 4-15mm(mean 8mm) whereas intraoperative CBD size
ranged between 6-23mm(mean 11mm). CBD calculi were seen in 7 cases
preoperatively. 1 patient whose CBD measured 6mm preoperatively had a
6mm stone present at IOC. 2 patients with CBD of 11mm and 14mm preop-
eratively had intraoperative CBDof 20 and 18mmrespectivelywith no calculi.
In 57 patients (Group 2), preoperative CBD was reported as normal on USS
but the size was not speciﬁed. On IOC, CBD size was 3-14mm(mean
6.8mm)with abnormalities not detected on pre-operative USS in 4 cases (1
CBD stone, 1 stricture, no ﬂow to duodenum in 2 cases).
Conclusions: There is poor correlation between CBD size measured pre-
and intraoperatively. It is difﬁcult to predict presence of CBD calculi at the
time of operation based on pre-operative imaging.1214: TIMING OF CHOLECYSTECTOMY FOLLOWING ACUTE ADMISSION
WITH CHOLELITHIASIS
Lewis Taylor, Andrew Torrance. Heart of England Foundation Trust,
Birmingham, UK.
Aim: There is increasing evidence supporting early over delayed
cholecystectomy for acute cholelithiasis. This study aims to identify factors
that could predict those who may beneﬁt from early cholecystectomy.
Method: A retrospective review of a prospectively maintained database of
emergency surgical admissions at a single centre was undertaken. Ad-
missions for acute cholelithiasis were identiﬁed over 6 months and fol-
lowed-up for 6 months. Data on patient demographics, admission details,
investigations, interventions and re-admissions were collected.
Results: 82 patients were identiﬁed (24(29.3%) male, median age 56(range
18-91)). 46(56.1%) patients had biliary colic, 33(40.2%) cholecystitis and
3(3.7%) cholangitis. 60(73%) patients had a cholecystectomy; 37(62%) on a
separate planned admission, 20(33%) during index admission, 3(5%) at a
subsequent emergency admission. No signiﬁcant difference in post-oper-
ative complications was seen between the groups. 19(23%) patients were
re-admitted with acute cholelithiasis within 6 months. There were no re-
admissions following cholecystectomy at index admission (p¼0.004).
Multiple logistic regression demonstrated no statistically signiﬁcant ef-
fects on the rate of in-patient cholecystectomy or re-admission when
adjusted for age, gender, sepsis, deranged liver function tests, in-
vestigations or cholecystitis. (Chi square¼15.6614;df¼9;p¼0.0743 and Chi
square¼8.6635;df¼8;p¼0.3715 respectively).
Conclusion: Early cholecystectomy for cholelithiasis is safe, effective and
signiﬁcant reduces the rate of re-admission with biliary complaints.1219: RADIOFREQUENCY ABLATION FOR COLORECTAL LIVER METASTA-
SES e A META-ANALYSIS
Christodoulos Neophytou, Antonis Valahis. Nottingham City Hospital,
Nottingham, UK.
Aims: The aim of themeta-analysis is to evaluate the comparative therapeutic
efﬁcacyof radiofrequencyablation (RFA)andhepatic resection (HR) for solitary
colorectal livermetastases (CLM)andtestwhetherRFA is superiorcomparedto
HR when it comes to survival (overall and disease free) and recurrence.
Methods: All studies citing the MeSH terms, ‘'ablation'' and ‘‘colorectal
liver metastasis'' were identiﬁed by searching the Medline database be-
tween March 2006 and March 2012. The outcome measures were the HRs
and 95% CIs for the disease free survival and overall survival as well as the
follow up period.
Results: From the 8 eligible studies overall survival and disease free sur-
vival are in favor of HR and this is statistically signiﬁcant (p-value¼ 0.0002
and <0.001 respectively). The risk of recurrence following RFA is 3.54
times greater compared to the one following hepatic resection.
Conclusions: Liver resection remains the best treatment option for solitary
resectable CLM - it is associated with acceptable morbidity providing
adequate patient selection. In contrast, RFA is associated with signiﬁcant
risk of local recurrence which generally translates into decreased survival
compared to resection. Currently, RFA cannot be considered a valuable
alternative to liver resection in case of resectable CLM.
